Financial Counselors Inc’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-126,429
Closed -$7.71M 70
2025
Q1
$7.71M Sell
126,429
-6,033
-5% -$352K 0.12% 162
2024
Q4
$7.49M Sell
132,462
-2,115
-2% -$118K 0.11% 167
2024
Q3
$6.96M Sell
134,577
-5,321
-4% -$250K 0.1% 166
2024
Q2
$5.81M Sell
139,898
-5,895
-4% -$264K 0.09% 176
2024
Q1
$7.91M Sell
145,793
-3,052
-2% -$155K 0.13% 152
2023
Q4
$7.64M Sell
148,845
-3,386
-2% -$178K 0.14% 152
2023
Q3
$8.84M Buy
152,231
+294
+0.2% +$18K 0.18% 134
2023
Q2
$9.72M Sell
151,937
-3,298
-2% -$221K 0.2% 125
2023
Q1
$10.8M Sell
155,235
-298
-0.2% -$21K 0.23% 114
2022
Q4
$11.2M Sell
155,533
-2,079
-1% -$157K 0.25% 109
2022
Q3
$11.2M Sell
157,612
-6,079
-4% -$441K 0.28% 103
2022
Q2
$12.6M Buy
163,691
+9,690
+6% +$738K 0.29% 101
2022
Q1
$11.2M Buy
154,001
+2,071
+1% +$139K 0.23% 115
2021
Q4
$9.47M Sell
151,930
-18,338
-11% -$1.08M 0.19% 135
2021
Q3
$10.1M Sell
170,268
-3,378
-2% -$222K 0.22% 126
2021
Q2
$11.6M Sell
173,646
-3,080
-2% -$201K 0.25% 116
2021
Q1
$11.2M Buy
176,726
+444
+0.3% +$27.6K 0.26% 112
2020
Q4
$10.9M Sell
176,282
-3,382
-2% -$208K 0.27% 104
2020
Q3
$10.8M Sell
179,664
-7,828
-4% -$471K 0.32% 91
2020
Q2
$11M Buy
187,492
+21,499
+13% +$1.29M 0.35% 88
2020
Q1
$9.25M Sell
165,993
-2,242
-1% -$137K 0.41% 81
2019
Q4
$10.8M Buy
168,235
+13,916
+9% +$797K 0.38% 85
2019
Q3
$7.83M Buy
154,319
+2,993
+2% +$141K 0.31% 105
2019
Q2
$6.86M Sell
151,326
-1,411
-0.9% -$65.7K 0.28% 120
2019
Q1
$7.29M Sell
152,737
-3,992
-3% -$199K 0.31% 108
2018
Q4
$8.15M Sell
156,729
-4,185
-3% -$225K 0.4% 77
2018
Q3
$9.99M Sell
160,914
-4,390
-3% -$261K 0.44% 76
2018
Q2
$9.15M Sell
165,304
-18,361
-10% -$992K 0.42% 77
2018
Q1
$11.6M Sell
183,665
-323
-0.2% -$20.8K 0.55% 56
2017
Q4
$11.3M Buy
183,988
+15
+0% +$938 0.52% 61
2017
Q3
$11.7M Buy
183,973
+15,730
+9% +$918K 0.57% 55
2017
Q2
$9.37M Buy
168,243
+49,345
+42% +$2.69M 0.47% 71
2017
Q1
$6.47M Sell
118,898
-1,064
-0.9% -$58.4K 0.33% 104
2016
Q4
$7.01M Buy
+119,962
New +$6.56M 0.37% 86
2016
Q2
$8.21M Buy
111,677
+34
+0% +$2.4K 0.49% 65
2016
Q1
$7.13M Sell
111,643
-464
-0.4% -$29.3K 0.44% 75
2015
Q4
$7.71M Sell
112,107
-2,935
-3% -$194K 0.5% 61
2015
Q3
$6.81M Sell
115,042
-4,822
-4% -$306K 0.47% 68
2015
Q2
$7.98M Buy
119,864
+7,656
+7% +$505K 0.51% 59
2015
Q1
$7.24M Sell
112,208
-32,245
-22% -$2.02M 0.45% 71
2014
Q4
$8.53M Sell
144,453
-5,171
-3% -$292K 0.54% 53
2014
Q3
$7.66M Buy
149,624
+8,289
+6% +$414K 0.54% 53
2014
Q2
$6.86M Sell
141,335
-7,456
-5% -$367K 0.48% 65
2014
Q1
$7.73M Sell
148,791
-5,825
-4% -$310K 0.56% 49
2013
Q4
$8.22M Sell
154,616
-64,664
-29% -$3.29M 0.62% 46
2013
Q3
$10.1M Sell
219,280
-6,017
-3% -$264K 0.84% 30
2013
Q2
$10.1M Buy
+225,297
New +$9.78M 0.84% 31

Other funds holding BMY

Financial Counselors Inc's BMY Position: Q2 2025 in Review

Financial Counselors Inc sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 126,429 shares — an estimated $7.71M sold.

Financial Counselors Inc first reported a position in BMY in Q2 2013 and held it in 47 quarters. The position peaked at $12.6M in Q2 2022. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Financial Counselors Inc reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Financial Counselors Inc sold 126,429 Bristol-Myers Squibb shares in Q2 2025, an estimated $7.71M.
  • Financial Counselors Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 47 quarters.
  • Financial Counselors Inc's Bristol-Myers Squibb position peaked at $12.6M in Q2 2022.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.